As if there weren't enough streaming platforms to choose from, Paramount+ and Showtime are giving customers another option to consider.

The two entities are merging to form Paramount+ with Showtime, a move that will integrate all of the premium cable network's content into a premium streaming tier on Paramount+. With more households cutting their cable cords, integrating content onto a streaming platform will allow more eyes on Showtime's content, Bob Bakish, Paramount CEO, said in a statement.

"Now, with SHOWTIME's content integrated into our flagship streaming service, and select Paramount+ originals joining the linear offering, Paramount+ will become the definitive multi-platform brand in the streaming space -– and the first of its kind to integrate streaming and linear content in this way," he said.

Chris McCarthy, president and CEO of Paramount Media Networks and Showtime, said that investments will be diverted away from unsuccessful projects to clear a path for the cable network's hit shows to reach a global audience.

"As a part of Paramount+, we can put more resources into building out the lanes that have made the SHOWTIME brand more famous, as well as turning our hit shows into global hit franchises," he said.

More information on the merger is expected to be revealed in the coming weeks. Paramount Global, parent company of Paramount+, is set to report earnings on February 16.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More